Patients’, physicians’, and pharmacists’ preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study-Reference-Cited by-同舟云学术

Patients’, physicians’, and pharmacists’ preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: results from the COHIBA Study

Published:2009-03 Issue:2 Volume:15 Page:473-486
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

SCALONE L.,MANTOVANI L. G.,BORGHETTI F.,VON MACKENSEN S.,GRINGERI A.

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2008.01926.x/fullpdf

Reference72 articles.

1. The presence of a circulating anti-coagulant in a male member of a haemophiliac family;Lawrence;Trans Am Clin Climatol Assoc,1941

2. Overview of inhibitors;Astermark;Semin Hematol,2006

3. The epidemiology of inhibitors in haemophilia A: a systematic review;Wight;Haemophilia,2003

4. Inhibitors: resolving diagnostic and therapeutic dilemmas;DiMichele;Haemophilia,2002

5. Prevalence of factor IX inhibitors among patients with hemophilia B: results of a large scale North American Survey;Katz;Haemophilia,1996

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient and caregiver preferences for haemophilia treatments: A discrete‐choice experiment;Haemophilia;2024-01-10

2. Patient preferences and cost-benefit of hypertension and hyperlipidemia collaborative management model between pharmacies and primary care in Portugal: A discrete choice experiment alongside a trial (USFarmácia®);PLOS ONE;2023-10-05

3. Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study;JMIR Public Health and Surveillance;2023-07-26

4. Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study (Preprint);2023-01-17

5. Shared decision-making for gene therapy in haemophilia care;The Journal of Haemophilia Practice;2023-01-01